HEADER OXIDOREDUCTASE 16-JAN-97 1DFG TITLE X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND TITLE 2 BENZO-DIAZABORINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL ACYL CARRIER PROTEIN REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENR; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PENVM5 KEYWDS OXIDOREDUCTASE, LIPID BIOSYNTHESIS, DIAZABORINE EXPDTA X-RAY DIFFRACTION AUTHOR C.BALDOCK,J.B.RAFFERTY,D.W.RICE REVDAT 5 03-APR-24 1DFG 1 REMARK REVDAT 4 07-FEB-24 1DFG 1 REMARK LINK REVDAT 3 13-JUL-11 1DFG 1 VERSN REVDAT 2 24-FEB-09 1DFG 1 VERSN REVDAT 1 28-JAN-98 1DFG 0 JRNL AUTH C.BALDOCK,J.B.RAFFERTY,S.E.SEDELNIKOVA,P.J.BAKER, JRNL AUTH 2 A.R.STUITJE,A.R.SLABAS,T.R.HAWKES,D.W.RICE JRNL TITL A MECHANISM OF DRUG ACTION REVEALED BY STRUCTURAL STUDIES OF JRNL TITL 2 ENOYL REDUCTASE. JRNL REF SCIENCE V. 274 2107 1996 JRNL REFN ISSN 0036-8075 JRNL PMID 8953047 JRNL DOI 10.1126/SCIENCE.274.5295.2107 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.BALDOCK,J.B.RAFFERTY,S.E.SEDELNIKOVA,S.BITHELL, REMARK 1 AUTH 2 A.R.STUITJE,A.R.SLABAS,D.W.RICE REMARK 1 TITL CRYSTALLIZATION OF ESCHERICHIA COLI ENOYL REDUCTASE AND ITS REMARK 1 TITL 2 COMPLEX WITH DIAZABORINE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 52 1181 1996 REMARK 1 REFN ISSN 0907-4449 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 20204 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1730 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 20204 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3800 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 25.500 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.014 ; 2.000 ; 4006 REMARK 3 BOND ANGLES (DEGREES) : 1.448 ; 3.000 ; 5404 REMARK 3 TORSION ANGLES (DEGREES) : 16.463; 0.000 ; 2344 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.010 ; 4.000 ; 86 REMARK 3 GENERAL PLANES (A) : 0.015 ; 9.000 ; 592 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : 0.368 ; 0.000 ; 46 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.85 REMARK 3 BSOL : 212.4 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH AND HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 INITIALLY THE NAD AND BENZO-DIAZABORINE WERE REFINED INDEPENDENTLY REMARK 3 AND NOT RESTRAINED BY THE COVALENT BOND BETWEEN THEM. AFTER TWO REMARK 3 CYCLES OF REFINEMENT IT WAS CLEAR THAT THEY WERE BOUND COVALENTLY REMARK 3 AND THIS RESTRAINT WAS ADDED. REMARK 3 REMARK 3 ASN A 155, ASN A 157, ASN B 155, ASN B 157 ARE THE RESIDUES REMARK 3 EITHER SIDE OF THE CATALYTIC TYROSINE AND HAVE DIHEDRAL REMARK 3 ANGLES WHICH LIE OUTSIDE THEIR EXPECTED RANGE. THIS IS REMARK 3 THOUGHT TO ALLOW THE TYROSINE SIDE-CHAIN TO OCCUPY THE REMARK 3 CORRECT POSITION WITH RESPECT TO THE POSITION OF THE REMARK 3 NICOTINAMIDE RING. REMARK 4 REMARK 4 1DFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172767. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-DEC-95 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AGROVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20393 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.540 REMARK 200 RESOLUTION RANGE LOW (A) : 23.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.09700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: E. COLI ENR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 400, PH5.0 100MM ACETATE, 5MM REMARK 280 NAD, 5MM 1,2-DIHYDRO-1-HYDROXY-2- (4-METHYLSULPHONYL)BENZO[E][1, REMARK 280 2,3]DIAZABORINE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 108.43333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 216.86667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 162.65000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 271.08333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.21667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 108.43333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 216.86667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 271.08333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 162.65000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 54.21667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 21730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 40.30000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 69.80165 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 271.08333 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 LEU B 259 REMARK 465 GLU B 260 REMARK 465 LEU B 261 REMARK 465 LYS B 262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 ARG B 204 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 205 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB ASP A 101 NZ LYS A 201 1.91 REMARK 500 CB ASP A 101 CE LYS A 201 1.95 REMARK 500 NH1 ARG B 8 OE1 GLU B 34 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU A 10 C VAL A 11 N 0.245 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 13 O - C - N ANGL. DEV. = -20.8 DEGREES REMARK 500 ALA A 95 CA - C - N ANGL. DEV. = 17.3 DEGREES REMARK 500 ALA A 95 O - C - N ANGL. DEV. = -16.3 DEGREES REMARK 500 ARG B 8 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 GLY B 13 O - C - N ANGL. DEV. = -16.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 63 114.33 -162.86 REMARK 500 SER A 145 -169.77 -109.77 REMARK 500 ASN A 155 -18.43 66.79 REMARK 500 ASN A 157 -117.22 42.25 REMARK 500 ALA A 196 -158.14 -51.87 REMARK 500 VAL B 65 5.19 -68.55 REMARK 500 SER B 121 -56.57 -126.38 REMARK 500 ASN B 155 -22.13 70.31 REMARK 500 ASN B 157 -126.97 35.43 REMARK 500 ALA B 196 -167.22 -46.49 REMARK 500 ASP B 248 22.76 -148.73 REMARK 500 ASN B 257 -6.02 -52.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY A 13 -23.62 REMARK 500 GLY A 56 -11.58 REMARK 500 ILE B 9 -12.71 REMARK 500 GLY B 13 -17.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDT A 0 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDT B 0 DBREF 1DFG A 2 262 UNP P29132 FABI_ECOLI 1 261 DBREF 1DFG B 2 262 UNP P29132 FABI_ECOLI 1 261 SEQRES 1 A 261 GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY VAL SEQRES 2 A 261 ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN ALA SEQRES 3 A 261 MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR GLN SEQRES 4 A 261 ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA ALA SEQRES 5 A 261 GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL ALA SEQRES 6 A 261 GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU GLY SEQRES 7 A 261 LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER ILE SEQRES 8 A 261 GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR VAL SEQRES 9 A 261 ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS ASP SEQRES 10 A 261 ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA CYS SEQRES 11 A 261 ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR LEU SEQRES 12 A 261 SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR ASN SEQRES 13 A 261 VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN VAL SEQRES 14 A 261 ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL ARG SEQRES 15 A 261 VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU ALA SEQRES 16 A 261 ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA HIS SEQRES 17 A 261 CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR ILE SEQRES 18 A 261 GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER ASP SEQRES 19 A 261 LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL ASP SEQRES 20 A 261 GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU LEU SEQRES 21 A 261 LYS SEQRES 1 B 261 GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY VAL SEQRES 2 B 261 ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN ALA SEQRES 3 B 261 MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR GLN SEQRES 4 B 261 ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA ALA SEQRES 5 B 261 GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL ALA SEQRES 6 B 261 GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU GLY SEQRES 7 B 261 LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER ILE SEQRES 8 B 261 GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR VAL SEQRES 9 B 261 ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS ASP SEQRES 10 B 261 ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA CYS SEQRES 11 B 261 ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR LEU SEQRES 12 B 261 SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR ASN SEQRES 13 B 261 VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN VAL SEQRES 14 B 261 ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL ARG SEQRES 15 B 261 VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU ALA SEQRES 16 B 261 ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA HIS SEQRES 17 B 261 CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR ILE SEQRES 18 B 261 GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER ASP SEQRES 19 B 261 LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL ASP SEQRES 20 B 261 GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU LEU SEQRES 21 B 261 LYS HET NAD A 501 44 HET NDT A 0 21 HET NAD B 501 44 HET NDT B 0 21 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM NDT 2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ- HETNAM 2 NDT 1-OL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 NDT 2(C14 H13 B N2 O3 S) HELIX 1 1 ILE A 20 ARG A 30 1 11 HELIX 2 2 ASP A 42 GLN A 54 5 13 HELIX 3 3 ASP A 68 VAL A 81 1 14 HELIX 4 4 GLY A 97 LEU A 100 5 4 HELIX 5 5 TYR A 104 ALA A 107 1 4 HELIX 6 6 ARG A 110 SER A 120 1 11 HELIX 7 7 TYR A 122 MET A 134 1 13 HELIX 8 8 LEU A 147 ALA A 149 5 3 HELIX 9 9 ASN A 157 GLU A 180 5 24 HELIX 10 10 PHE A 203 VAL A 213 1 11 HELIX 11 11 ILE A 222 CYS A 233 1 12 HELIX 12 12 ASP A 235 SER A 237 5 3 HELIX 13 13 PHE A 251 ILE A 253 5 3 HELIX 14 14 ILE B 20 ARG B 30 1 11 HELIX 15 15 ASP B 42 LEU B 55 1 14 HELIX 16 16 ASP B 68 VAL B 81 1 14 HELIX 17 17 GLY B 97 LEU B 100 5 4 HELIX 18 18 TYR B 104 ALA B 107 1 4 HELIX 19 19 ARG B 110 SER B 120 1 11 HELIX 20 20 TYR B 122 MET B 134 1 13 HELIX 21 21 LEU B 147 ALA B 149 5 3 HELIX 22 22 ASN B 157 GLU B 180 1 24 HELIX 23 23 PHE B 203 VAL B 213 1 11 HELIX 24 24 ILE B 222 CYS B 233 1 12 HELIX 25 25 ASP B 235 SER B 237 5 3 HELIX 26 26 PHE B 251 ILE B 253 5 3 SHEET 1 A 3 ARG A 8 VAL A 11 0 SHEET 2 A 3 GLU A 34 TYR A 39 1 N GLU A 34 O ILE A 9 SHEET 3 A 3 VAL A 60 GLN A 62 1 N LEU A 61 O PHE A 37 SHEET 1 B 4 GLY A 87 HIS A 90 0 SHEET 2 B 4 SER A 139 TYR A 146 1 N ALA A 140 O PHE A 88 SHEET 3 B 4 VAL A 182 ALA A 189 1 N ARG A 183 O SER A 139 SHEET 4 B 4 GLU A 243 VAL A 247 1 N GLU A 243 O ALA A 186 SHEET 1 C 3 ARG B 8 VAL B 11 0 SHEET 2 C 3 GLU B 34 TYR B 39 1 N GLU B 34 O ILE B 9 SHEET 3 C 3 VAL B 60 GLN B 62 1 N LEU B 61 O PHE B 37 SHEET 1 D 4 GLY B 87 HIS B 90 0 SHEET 2 D 4 ALA B 140 SER B 145 1 N ALA B 140 O PHE B 88 SHEET 3 D 4 ARG B 183 ALA B 189 1 N ARG B 183 O LEU B 141 SHEET 4 D 4 VAL B 244 VAL B 247 1 N VAL B 245 O ALA B 186 LINK B1 NDT A 0 O2D NAD A 501 1555 1555 1.37 LINK B1 NDT B 0 O2D NAD B 501 1555 1555 1.53 SITE 1 AC1 17 NDT A 0 GLY A 13 ALA A 15 SER A 19 SITE 2 AC1 17 ILE A 20 GLN A 40 CYS A 63 ASP A 64 SITE 3 AC1 17 VAL A 65 SER A 91 ILE A 92 SER A 145 SITE 4 AC1 17 LYS A 163 ALA A 189 GLY A 190 PRO A 191 SITE 5 AC1 17 ILE A 192 SITE 1 AC2 10 GLY A 93 PHE A 94 ALA A 95 LEU A 100 SITE 2 AC2 10 TYR A 146 TYR A 156 MET A 159 LYS A 163 SITE 3 AC2 10 ILE A 200 NAD A 501 SITE 1 AC3 20 NDT B 0 GLY B 13 VAL B 14 ALA B 15 SITE 2 AC3 20 SER B 19 ILE B 20 GLN B 40 CYS B 63 SITE 3 AC3 20 ASP B 64 VAL B 65 SER B 91 ILE B 92 SITE 4 AC3 20 GLY B 93 LEU B 144 SER B 145 LYS B 163 SITE 5 AC3 20 ALA B 189 GLY B 190 PRO B 191 ILE B 192 SITE 1 AC4 8 GLY B 93 PHE B 94 ALA B 95 LEU B 100 SITE 2 AC4 8 TYR B 156 MET B 159 LYS B 163 NAD B 501 CRYST1 80.600 80.600 325.300 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012407 0.007163 0.000000 0.00000 SCALE2 0.000000 0.014326 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003074 0.00000 MTRIX1 1 -0.642000 0.620000 -0.452000 39.01000 1 MTRIX2 1 0.619000 0.070000 -0.782000 145.59000 1 MTRIX3 1 -0.453000 -0.782000 -0.428000 229.89999 1